Angelica Benefits

Angelica — Angelica archangelica L., European garden angelica, family Apiaceae — is a plant that earned its place in history through flavour rather than through cure. Its aromatic root and seed are the medicinal parts; its thick young stems are the ones candied bright green for cakes and trifles; and it is one of the defining botanicals in gin, Chartreuse and Bénédictine. Northern European monastery gardens grew it for centuries as a warming digestive bitter, a winter cough remedy and a plant of protection.

Here is the honest headline before you read any further: the human evidence for angelica is thin. Not absent — but thin, and mostly pointing somewhere nobody expected. The only decent randomised trials on A. archangelica are about the bladder, not the gut, the chest or the nerves, and the first of them missed its primary endpoint. Everything else is centuries of European tradition plus a modest body of cell-culture and rodent work. This set of pages says so plainly, because a page that admits an herb has not been tested is more useful than one that dresses laboratory findings up as treatment.

Two clarifications that matter more here than for almost any other herb on this site:

1. This is not Dong Quai. Angelica sinensis — dang gui, the Chinese blood tonic — is a different species with different chemistry, a different tradition and different uses. Shared genus, nothing more. See Dong Quai for that plant.
2. The furanocoumarins in this plant are real and measurable. A. archangelica genuinely carries angelicin, imperatorin, xanthotoxin (methoxsalen) and bergapten (5-methoxypsoralen). These are the same class of molecules used as prescription photosensitising drugs in PUVA therapy. They create a genuine phototoxicity risk and a plausible CYP3A4 drug-interaction concern. The safety article covers this in detail, along with the potentially fatal look-alike problem.

Table of Contents

1. Deep-Dive Articles
2. What Angelica Actually Is
3. Not Dong Quai — The Genus Confusion
4. The Chemistry That Matters
5. Where the Evidence Actually Stands
6. Forms, Dosing and Label Checking
7. Key Research Papers
8. External Resources
9. Connections

Deep-Dive Articles

Four articles go deeper than the main Angelica page. If you read only one, read the safety article — it is the one with consequences.

What Angelica Actually Is

Angelica archangelica is a stout biennial or short-lived perennial of cool, damp northern Europe — Iceland, Scandinavia, the Alps, the north of Britain, and eastward across northern Eurasia. In its second year it throws up a hollow, ridged stem that can pass head height, topped by nearly spherical umbels of small greenish-white to yellowish-green flowers. Bruise any part and it smells strongly aromatic: celery and juniper with something sweet and musky underneath.

Different parts of the plant have entirely different jobs, and mixing them up is the fastest route to misreading the research:

• Root (Angelicae archangelicae radix) — the classic medicinal part in European herbal practice. Richest in essential oil and in furanocoumarins. This is the part in bitters, gin and the traditional digestive tincture.
• Fruit / “seed” — botanically a dry schizocarp, warm and peppery. Used as a flavouring and, in Iceland, as the source material for the tincture studied in the earliest laboratory work on this plant.
• Leaf — the part used in SagaPro, the Icelandic supplement behind every human clinical trial on A. archangelica. If you read “angelica works for the bladder,” the study behind it almost certainly used leaf extract, not root.
• Stem — confectionery. Candied angelica is food, not medicine, and nothing on these pages should be read as a claim about a slice of fruitcake.

That last point deserves emphasis. Angelica in its everyday form — candied stem, a botanical note in gin, a pinch of seed in baking — has centuries of ordinary culinary use behind it. The cautions on these pages attach to concentrated preparations: tinctures, capsules, standardised extracts and above all the essential oil.

Not Dong Quai — The Genus Confusion

The genus Angelica contains well over a hundred species, and at least three of them are important medicinal plants in completely separate traditions. English-language writing conflates them constantly.

• Angelica archangelica — European garden angelica. Northern European monastic and folk medicine. Digestive bitter, expectorant, culinary and distilling botanical. This is the plant these pages describe.
• Angelica sinensis — Dong Quai, dang gui, 當歸. Chinese herbal medicine. A blood-nourishing and blood-moving herb, used almost always inside multi-herb formulas for menstrual complaints, anaemia patterns and pain. Its marker compounds are ferulic acid, ligustilide and immunologically active polysaccharides — a different chemical profile entirely.
• Angelica dahurica — bai zhi, 白芷. Another East Asian drug, used for headache and nasal congestion, and itself a rich source of furanocoumarins.

Two things follow. First, the traditions are independent, not borrowed. European herbalists described angelica as “warming the blood” centuries before any contact with Chinese medical texts, and the resemblance in language is convergence, not transmission. Nothing in the European record derives from the Chinese use of A. sinensis, and nothing in Chinese practice derives from the European use of A. archangelica.

Second, and practically: read the Latin binomial on the label. A capsule marked only “Angelica Root 500 mg” tells you almost nothing. The two plants have different safety profiles — the furanocoumarin and photosensitivity problem discussed throughout these pages belongs to A. archangelica, while A. sinensis carries its own separate cautions around bleeding and hormone-sensitive conditions.

The Chemistry That Matters

Angelica’s pharmacology, such as it is, comes down to two chemical families.

The essential oil — terpenes

Root essential oil of A. archangelica is dominated by monoterpene hydrocarbons, typically with α-pinene as the largest single component and β-phellandrene, δ-3-carene, limonene, α-phellandrene, sabinene and myrcene making up much of the rest. Analyses vary widely with provenance, plant part and distillation method — published root oils have reported α-pinene anywhere from roughly a tenth to a quarter of the oil, which is exactly why two papers on “angelica oil” can read like two different substances. Larger, less volatile molecules — the macrocyclic musk lactones — give the oil its distinctive animalic base note and are why perfumers pay attention.

Angelica also carries phthalides, the celery-and-lovage aroma compounds, and angelic acid, an unsaturated short-chain acid named for this plant and found in it as esters.

The furanocoumarins — the part with consequences

This is where A. archangelica parts company with most kitchen herbs. It is a genuine furanocoumarin plant, containing:

• Imperatorin — a linear furanocoumarin, the compound with the most pharmacology research attached.
• Xanthotoxin (8-methoxypsoralen, methoxsalen) — a licensed pharmaceutical in its own right, given deliberately with UVA light as PUVA therapy for psoriasis and vitiligo.
• Bergapten (5-methoxypsoralen) — likewise a photosensitising drug, and the compound behind the classic bergamot-oil perfume dermatitis.
• Angelicin — an angular furanocoumarin, structurally distinct from the linear psoralens above and named for this genus.

One concrete number puts the scale in perspective. When Icelandic pharmacists analysed SagaPro tablets — an A. archangelica leaf product — they found 280 µg of xanthotoxin and 2 µg of imperatorin per tablet, along with 158 µg of the flavonoid isoquercitrin that the manufacturer had proposed as the active principle. Their conclusion about that flavonoid was blunt: at 158 µg by mouth it is “highly unlikely to have an effect on nocturia or any other pharmacologically significant effect in humans.” A root tincture or an essential oil is a far more concentrated furanocoumarin source than a leaf tablet, which is why the phototoxicity caution scales with the preparation.

Where the Evidence Actually Stands

Here is the whole human evidence base for Angelica archangelica, stated without padding.

The bladder trials — the only real human data

An Icelandic company, SagaMedica, developed SagaPro from A. archangelica leaf and tested it for nocturia — getting up at night to urinate. The 2013 trial randomised 69 men aged 45 and over with at least two nightly voids to SagaPro or placebo for eight weeks. It did not work. The number of nocturnal voids, the nocturnal polyuria index and the nocturnal bladder capacity index all fell — in both groups — with no significant difference between them. A post-hoc subgroup with reduced nocturnal bladder capacity did show a benefit, and the authors reported this honestly as hypothesis-generating rather than as a result. The product was safe. It simply did not beat placebo on the endpoint it was designed to test.

A Spanish group revisited the question in 2025 with a larger pilot randomised controlled trial in 143 adults with overactive bladder, using A. archangelica extract for six weeks. Here the picture was better: significant improvement versus placebo in daytime voiding frequency (p = 0.004), in the storage subscore of the International Prostate Symptom Score (p = 0.025) and in quality of life (p < 0.001). Nocturia itself only approached significance (p = 0.069). The effect sizes were small (partial η² of 0.03–0.12), it is explicitly labelled a pilot, and it needs replication by an independent group before anyone should treat it as established. But it is a real, registered, placebo-controlled trial, and it is the strongest single piece of human evidence this plant has.

Iberogast (STW 5) — real trials, but not really about angelica

Angelica root is one ingredient in STW 5 (Iberogast), a nine-herb liquid with genuine randomised evidence in functional dyspepsia, including a meta-analysis. The problem is arithmetic: the other eight herbs are bitter candytuft, peppermint, chamomile, liquorice, caraway, milk thistle, lemon balm and greater celandine, several of which have stand-alone digestive evidence of their own. Attributing the combination’s result to angelica is not a conclusion the trials support. The digestive article works through this properly.

Everything else — cells and rodents

• Antiproliferative in cell culture. A fruit tincture inhibited growth of the PANC-1 human pancreatic cancer line with an EC₅₀ of 28.6 µg/mL, and the activity tracked almost entirely to imperatorin (EC₅₀ 2.7 µg/mL) and xanthotoxin (3.7 µg/mL), not to the terpenes. This is a dish, not a patient.
• Tumour growth in mice. A leaf extract fed to mice implanted with a breast cancer line markedly slowed tumour growth — and, notably, the authors could not explain the effect by the furanocoumarin content. Interesting; twenty years old; never followed into humans.
• Anxiety-like behaviour in rodents. Isolated coumarins reduced anxiety-like behaviour in standard maze tests at 5–10 mg/kg by mouth.
• Acetylcholinesterase inhibition. Extracts and constituents inhibit the enzyme in vitro, and oral imperatorin affected memory tasks in mice.
• Seizures — a negative result worth stating. In a 2025 electroshock seizure model, A. archangelica extract at 100 mg/kg produced only “moderate, non-significant” anticonvulsant activity, while a comparator herb in the same experiment worked. Publishing that alongside the positive findings is the point.
• Antibacterial and antifungal. Root essential oil inhibits a range of bacteria and moulds in vitro. Almost every essential oil does. This is not evidence of an infection treatment.

The honest summary

Angelica is a traditional aromatic bitter and a superb flavouring agent with one emerging, unreplicated line of human evidence in urinary symptoms and a body of preliminary laboratory work. It is not a treatment for any disease. Use it for what it demonstrably is — a pleasant, warming digestive aromatic — and keep the safety section firmly in mind.

Forms, Dosing and Label Checking

There is no official, evidence-based therapeutic dose for angelica, because there is no body of dose-ranging human trials to derive one from. What follows is traditional European practice, presented as tradition.

• Root infusion / decoction — roughly 1–2 g of dried root per cup, steeped 10–15 minutes, up to three cups a day, taken 15–30 minutes before meals when used as a bitter.
• Tincture — traditionally 0.5–2 mL of a 1:5 root tincture in a little water before meals. Taste it: a bitter that you cannot taste is not doing the thing bitters are supposed to do.
• Seed — culinary quantities as a baking and flavouring spice.
• Leaf extract capsules — the SagaPro-type products used in the bladder trials. If you are trying angelica for urinary symptoms specifically, this is the form that was actually studied.
• Essential oil — do not swallow it. Angelica root oil is a concentrated furanocoumarin source and is a recognised phototoxic material; the fragrance industry restricts its use in leave-on skin products for exactly that reason.

What to check on a label: the full Latin binomial (Angelica archangelica, not just “Angelica”); the plant part (root, leaf or fruit — they are not interchangeable); the extract ratio or a stated standardisation; a batch number and a third-party contaminant test if you can get one. Apiaceae roots are grown in soil and can carry heavy metals, so provenance is not a trivial question. If the label says only “Angelica” with no species and no plant part, you do not know what is in the bottle.

Key Research Papers

Every identifier below was checked live against NCBI E-utilities — first author, title, journal and year all had to match before a PMID was printed. Where a claim could not be tied to a specific confirmed paper, the entry links a PubMed topic search instead of a number that might point at the wrong article.

Human trials — the urinary tract

1. López-Seoane J, Gesteiro E, Castro-Alija MJ, Quesada-González C, Pérez-Ruiz M, González-Gross M. Effects of Angelica archangelica extract on overactive bladder: a pilot randomized controlled trial. Food Science & Nutrition. 2025;13(12):e71258.
2. Sigurdsson S, Geirsson G, Gudmundsdottir H, Egilsdottir PB, Gudbjarnason S. A parallel, randomized, double-blind, placebo-controlled study to investigate the effect of SagaPro on nocturia in men. Scandinavian Journal of Urology. 2013;47(1):26–32. Negative on its primary endpoint — no significant difference from placebo overall.
3. Kowal NM, Eyjolfsson R, Olafsdottir ES. Investigations on the constituents of SagaPro tablets, a food supplement manufactured from Angelica archangelica leaf. Die Pharmazie. 2017;72(1):3–4.

Chemistry and essential oil

1. Fraternale D, Flamini G, Ricci D. Essential oil composition and antimicrobial activity of Angelica archangelica L. (Apiaceae) roots. Journal of Medicinal Food. 2014;17(9):1043–1047.
2. Aćimović MG, Pavlović SĐ, Varga AO, et al. Chemical composition and antibacterial activity of Angelica archangelica root essential oil. Natural Product Communications. 2017;12(2):205–206.
3. Korpinen RI, Välimaa AL, Liimatainen J, Kunnas S. Essential oils and supercritical CO₂ extracts of Arctic angelica (Angelica archangelica L.), marsh Labrador tea and common tansy. Molecules. 2021;26(23).
4. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. A review of the composition of the essential oils and biological activities of Angelica species. Scientia Pharmaceutica. 2017;85(3).

Nervous system — rodent and in vitro

1. Kumar D, Bhat ZA, Kumar V, Shah MY. Coumarins from Angelica archangelica Linn. and their effects on anxiety-like behavior. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2013;40:180–186.
2. Sigurdsson S, Gudbjarnason S. Inhibition of acetylcholinesterase by extracts and constituents from Angelica archangelica and Geranium sylvaticum. Zeitschrift für Naturforschung C. 2007;62(9–10):689–693.
3. Suciu F, Mihai DP, Ungurianu A, et al. Investigation of anticonvulsant potential of Morus alba, Angelica archangelica, Valeriana officinalis and Passiflora incarnata extracts. International Journal of Molecular Sciences. 2025;26(13):6426. Angelica extract was non-significant in this model.

Cell culture and animal tumour work

1. Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. Antiproliferative effect of Angelica archangelica fruits. Zeitschrift für Naturforschung C. 2004;59(7–8):523–527.
2. Sigurdsson S, Ogmundsdottir HM, Hallgrimsson J, Gudbjarnason S. Antitumour activity of Angelica archangelica leaf extract. In Vivo. 2005;19(1):191–194.

Digestion — the combination-product evidence

1. Melzer J, Rösch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Alimentary Pharmacology & Therapeutics. 2004;20(11–12):1279–1287.
2. Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine. 2006;13(Suppl 5):114–121.

Safety — furanocoumarins and look-alikes

1. Melough MM, Cho E, Chun OK. Furocoumarins: a review of biochemical activities, dietary sources and intake, and potential health risks. Food and Chemical Toxicology. 2018;113:99–107.
2. Irizar A, Boislève F, Gautier F, et al. Phototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extracts. Food and Chemical Toxicology. 2025;200:115332.
3. Karakasi MV, Tologkos S, Papadatou V, Raikos N, Lambropoulou M, Pavlidis P. Conium maculatum intoxication: literature review and case report on hemlock poisoning. Forensic Science Review. 2019;31(1):23–36.
4. Flanagan KE, Blankenship K, Houk L. Botanical briefs: phytophotodermatitis caused by giant hogweed (Heracleum mantegazzianum). Cutis. 2021;108(5):251–253.

Live PubMed Searches

1. Angelica archangelica
2. Angelica archangelica clinical trials
3. SagaPro and nocturia
4. Imperatorin pharmacology
5. Angelicin
6. Furocoumarin phototoxicity
7. Furanocoumarins and CYP3A4
8. Poison hemlock poisoning
9. Giant hogweed burns
10. STW 5 and functional dyspepsia
11. Angelica sinensis (Dong Quai)
12. Apiaceae allergy cross-reactivity

External Resources

• ClinicalTrials.gov NCT04357223 — the registration record for the 2025 overactive-bladder pilot trial.
• PubChem — imperatorin
• PubChem — xanthotoxin (methoxsalen)
• PubChem — bergapten (5-MOP)
• PubChem — angelicin
• Kew — Plants of the World Online — authoritative botanical records for Angelica species.
• NCCIH — Herbs at a Glance
• PubMed — all Angelica archangelica literature

Connections

• All Herbs
• Angelica — the main topic page.
• Digestive and Bitter Tonic
• Respiratory and Circulation
• Anxiety, Sleep and Nervous System
• Safety: Furanocoumarins and Look-Alikes
• Dong Quai — Angelica sinensis, a different species and a separate tradition.
• Fennel — fellow Apiaceae carminative.
• Lovage — the closest culinary relative in flavour and use.
• Chen Pi — aged citrus peel, the East Asian aromatic digestive.

Back to Table of Contents